Zephyrnet Logo

Novartis Asks Court To Ban Generic MS Drug Pending Trial

Date:

Novartis AG asked a London court on Thursday to ban rival Teva Pharmaceuticals and three other drugmakers from selling any generic versions of a multiple sclerosis drug while the pharmaceutical giant takes the patent battle to trial.

spot_img

Latest Intelligence

spot_img

Chat with us

Hi there! How can I help you?